|
Volumn 6, Issue 5, 2001, Pages 428-434
|
Activity of infusional etoposide, vincristine, and doxorubicin with bolus cyclophosphamide (EPOCH) in relapsed Hodgkin's disease
|
Author keywords
Chemotherapy; EPOCH; Hodgkin's; Relapse
|
Indexed keywords
BLEOMYCIN;
CHLORMETHINE;
DACARBAZINE;
DOXORUBICIN;
ETOPOSIDE;
PREDNISONE;
PROCARBAZINE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
VINBLASTINE;
VINCRISTINE;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RECURRENCE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG ACTIVITY;
FEMALE;
HODGKIN DISEASE;
HUMAN;
MALE;
PRIORITY JOURNAL;
ADMINISTRATION, ORAL;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HODGKIN DISEASE;
HUMANS;
INFUSIONS, INTRAVENOUS;
INJECTIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
PREDNISONE;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 0034749852
PISSN: 10837159
EISSN: None
Source Type: Journal
DOI: 10.1634/theoncologist.6-5-428 Document Type: Article |
Times cited : (6)
|
References (11)
|